Update on Regarding the Import Alert on Ranbaxy’s Toansa Plant
Ranbaxy Laboratories Limited announced that the US FDA notified the…
24 January 2014 | By Daiichi Sankyo Company
Ranbaxy Laboratories Limited announced that the US FDA notified the company that it is prohibited from manufacturing and distributing active pharmaceutical ingredients from its facility in Toansa, India, for FDA-regulated drug products...